Showing 8 of 8 recruiting trials for “Genetic hemoglobinopathy”
A Phase I Study of SNH-119014 in Healthy Volunteers
A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)
Effect of Exercise on Body Composition and Bone Health in Patients With Thalassemia
👨⚕️ Ellen Fung, PhD, University of California, San Francisco📍 2 sites📅 Started Dec 2024View details ↗
Enrolling by InvitationNCT07003256 ↗
Observational Study: Romiplostim for Platelet Recovery in Haploidentical HSCT
👨⚕️ Xiaoyang Yang, MD, Department of Hematology, Haikou People's Hospital📍 1 site📅 Started Sep 2024View details ↗
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Fetal Cell Receptors Repertoire
👨⚕️ Sélim ARACTINGI, MD, PHD, Dermatology unit, Cochin Hospital - APHP📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06071377 ↗
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
👨⚕️ Julie Kanter, MD, National Alliance for Sickle Cell Centers📍 10 sites📅 Started Apr 2023View details ↗
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →